L’uso delle medicazioni DuoDERM® si è dimostrato utile nel supportare la guarigione delle lesioni entro un protocollo di assistenza.
Le medicazioni DuoDERM® sono associate a una migliore guarigione delle lesioni croniche rispetto alle medicazioni tradizionali e ad altre medicazioni idrocolloidali.
There is evidence that wound improvement is more likely with GranuFLEX® and DuoDERM® Dressings than other hydrocolloids in the management of pressure sores.
In a prospective, controlled multicenter clinical study of 52 patients it was observed that:3
41 of 52 patients had improved wounds when DuoDERM® dressings were used as compared with 31 of 51 patients managed with Tegasorb™a (a hydrocolloid dressing).
In a meta-analysis of the randomized controlled trials (RCT) on hydrocolloid occlusive dressings versus conventional gauze in the healing of chronic wounds: 4
Analysis of the 11 papers that met the inclusion criteria found that complete healing occurred in 51% of ulcers in the hydrocolloid group as compared to 38% in the conventional group.
A review of economic studies in wound care management demonstrated that GranuFLEX® and DuoDERM® Dressings can reduce the overall cost of care and is cost-effective for the management of pressure sores and leg ulcers.
A cost study by Kerstein et al 5 concluded that:
The cost per venous ulcer healed over 12 weeks was lower for GranuFLEX® and DuoDERM® Dressings than impregnated gauze dressings.
GranuFLEX® and DuoDERM® Dressings were more cost-effective than competitor hydrocolloids and saline gauze in the treatment of pressure ulcers over a 12 week period
The European Pressure Ulcer Advisory Panel (EPUAP) and The National Pressure Ulcer Advisory Panel (NPUAP) guidelines recommend the usage of hydrocolloids for the management of pressure ulcers.
Category/stage 1: Intact skin with non-blanchable redness of localized area, usually over a bony prominence. Darkly pigmented skin may not have visible blanching; its color may differ from the surrounding area.
"Consider using hydrocolloid dressings to protect body areas at risk for friction injury or risk of injury from tape. (Strength of Evidence=C)"
Category/stage 2: Partial thickness loss of dermis presenting as a shallow open ulcer with a red/pink wound bed, without slough. It may also present as an intact or open/ruptured serum-filled blister.
"Use hydrocolloid dressings for clean Category/Stage II pressure ulcers in body areas where they will not roll or melt. (Strength of Evidence=B)"
a Tegasorb™ is a trademark of the 3M Company.